Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Abstract Background There is no doubt that genetic factors have the potential to predict the therapeutic outcomes of antidepressants in patients with major depressive disorder (MDD). This study investigated the association between genetic variants involved in serotonin signaling and brain-derived ne...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Dominika Jarčušková, Ivan Tkáč, Nataša Hlaváčová, Alena Stančáková Yaluri, Miriam Kozárová, Viera Habalová, Lucia Klimčáková, Jozef Židzik, Martin Javorský, Aneta Bednářová
פורמט: Article
שפה:English
יצא לאור: BMC 2024-10-01
סדרה:BMC Psychiatry
נושאים:
Pharmacogenetics
Depression
Escitalopram
Genetic Polymorphisms
SLC6A4
גישה מקוונת:https://doi.org/10.1186/s12888-024-06162-8

אינטרנט

https://doi.org/10.1186/s12888-024-06162-8

פריטים דומים